The CTC facilitates high quality clinical research in lung cancer in Australia and New Zealand.
In recent years, this has expanded into new trials looking at immunotherapy and targeted therapies for lung cancers, as well as renewed interest in mesothelioma, and most recently expanding into genomic profiling to deliver personalised precision medicine.
